Insulet Corporation (PODD) Guidance & Earnings Results
On 2026-08-05 Insulet Corporation mixed guidance: "FY26 Total Omnipod growth 21-23% (prior 22-24%); U.S. Omnipod 17-19% (prior 20-22%); International Omnipod 30-32% (prior 26-28%); Drug Delivery ~(40%) (prior ~(50%)); Total revenue 20-22% (prior 21-23%); Adj. operating…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PODDInsulet CorporationFollow PODD — free
—
Price chart with a free account
- Market cap
- 10.3B
- P/E TTM
- 27.9
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 5 Aug 26 | Mixed | FY26 Total Omnipod growth 21-23% (prior 22-24%); U.S. Omnipod 17-19% (prior 20-22%); International Omnipod 30-32% (prior 26-28%); Drug Delivery ~(40%) (prior ~(50%)); Total revenue 20-22% (prior 21-23%); Adj. operating margin ~100bps YoY expansion; Adj. EPS growth >25% (prior >30%); Q3 Total Omnipod 18-20%; Q3 Total revenue 17.5-19.5% · full year |
| 6 May 26 | Raised | FY2026 total Omnipod revenue growth raised from 21-23% to 22-24% constant currency; U.S. Omnipod unchanged at 20-22%; International Omnipod raised from 24-26% to 26-28% · full year |
| 6 Nov 25 | Raised | FY 2025 Total Omnipod guidance raised to 29%-30% from 25%-28%; Gross Margin guidance raised to >71% from ~71% · full year |
| 7 Aug 25 | Raised | FY2025 total Omnipod revenue growth raised to 25-28% from 20-23%; FY2025 adjusted operating margin raised to ~16.5% (from unspecified prior); Q3 2025 total revenue growth 22-25%. · full year |
Insulet Corporation — questions
- What guidance did Insulet Corporation give?
- On 2026-08-05: "FY26 Total Omnipod growth 21-23% (prior 22-24%); U.S. Omnipod 17-19% (prior 20-22%); International Omnipod 30-32% (prior 26-28%); Drug Delivery ~(40%) (prior ~(50%)); Total revenue 20-22% (prior 21-23%); Adj. operating margin ~100bps YoY expansion; Adj. EPS growth >25% (prior >30%); Q3 Total Omnipod"
- When does Insulet Corporation report earnings?
- Insulet Corporation's next earnings report is expected on 2026-11-04.
Every figure on this page comes from Insulet Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.